Whilst it is unclear if this extends to small molecule drugs acting as haptens, it nonetheless suggests that ‘quality over quantity’ might be important for IgE-dependent anaphylaxis, which has implications for the identification of culprit pathways. The gene discussed is IGHE; the disease is anaphylaxis.